CANF

CANF Operating Expenses

$10.14MTTM · USD

Period ending:

CANF FY Operating ExpensesUSD
CANF FY Operating Expenses2010-12-31: $4.51M2011-12-31: $5.27M2012-12-31: $6.00M2013-12-31: $8.99M2014-12-31: $7.13M2015-12-31: $6.58M2016-12-31: $8.80M2017-12-31: $8.22M2018-12-31: $9.23M2019-12-31: $14.04M2020-12-31: $14.90M2021-12-31: $13.70M2022-12-31: $10.91M2023-12-31: $8.94M2024-12-31: $8.80M2025-12-31: $10.41M$14.90M$0.00
2010-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CANF operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 16 observations from Dec 31, 2010 to Dec 31, 2025.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
10,412,955
8,804,000
8,938,000
10,906,000
13,695,000
14,902,000
14,039,000
9,234,000
8,220,451
8,803,358
6,579,722
7,132,382
8,991,241
6,004,379
5,267,997
4,509,031

Compare operating expenses

All CANF financial metrics · CANF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.